Goldman Sachs Group Inc Gilead Sciences, Inc. Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $998,850 - $1.26 Million	-15,000 Reduced 26.04%	42,600 $3.57 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $1.49 Million - $1.82 Million	-20,800 Reduced 26.53%	57,600 $4.22 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $1.09 Million - $1.24 Million	-14,900 Reduced 15.97%	78,400 $6.35 Million
Q3 2023 May 14, 2024	BUY	$73.94 - $80.67 $1.1 Million - $1.2 Million	14,900 Added 19.01%	93,300 $6.99 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $2.25 Million - $2.45 Million	-30,400 Reduced 24.58%	93,300 $6.99 Million
Q2 2023 May 14, 2024	SELL	$76.01 - $86.7 $4.26 Million - $4.86 Million	-56,100 Reduced 31.2%	123,700 $9.53 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $4.26 Million - $4.86 Million	-56,100 Reduced 31.2%	123,700 $9.53 Million
Q1 2023 May 14, 2024	BUY	$77.31 - $88.08 $3.88 Million - $4.42 Million	50,200 Added 38.73%	179,800 $14.9 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $3.88 Million - $4.42 Million	50,200 Added 38.73%	179,800 $14.9 Million
Q4 2022 May 14, 2024	BUY	$62.32 - $89.47 $6.2 Million - $8.9 Million	99,500 Added 330.56%	129,600 $11.1 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $6.2 Million - $8.9 Million	99,500 Added 330.56%	129,600 $11.1 Million
Q3 2022 May 14, 2024	SELL	$59.54 - $68.01 $6.16 Million - $7.04 Million	-103,500 Reduced 77.47%	30,100 $1.86 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $6.16 Million - $7.04 Million	-103,500 Reduced 77.47%	30,100 $1.86 Million
Q2 2022 May 14, 2024	BUY	$57.72 - $65.01 $3.19 Million - $3.59 Million	55,200 Added 70.41%	133,600 $8.26 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.94 Million - $3.32 Million	-51,000 Reduced 27.63%	133,600 $8.26 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $689,248 - $863,702	-11,900 Reduced 6.06%	184,600 $11 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $707,192 - $802,676	10,900 Added 5.87%	196,500 $14.3 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $12.6 Million - $13.6 Million	185,600 New	185,600 $13 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account